Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review
V Vannappagari, L Ragone, C Henegar… - Antiviral …, 2019 - journals.sagepub.com
Background Pretreatment and acquired drug resistance mutations (DRMs) can limit
antiretroviral therapy effectiveness. Methods We review prevalence of DRMs with resistance …
antiretroviral therapy effectiveness. Methods We review prevalence of DRMs with resistance …
Naturally occurring mutations in HIV-1 protease gene among people living with HIV
Z Hasanshahi, A Hashempour, J Moayedi… - Acta Medica …, 2023 - acta.tums.ac.ir
The emergence of resistance to antiretroviral drugs is the main problem in their long-term
efficacy and by considering the wide use of protease inhibitors (PIs), monitoring drug …
efficacy and by considering the wide use of protease inhibitors (PIs), monitoring drug …
Incidence of hepatotoxicity in Iranian patients with HIV on antiretroviral therapies and its correlation with virologic response to HIV treatment
Objective To investigate hepatotoxicity in Iranian patients with HIV to assess the association
between virologic response to HIV treatment and serum alanine aminotransferase (ALT) …
between virologic response to HIV treatment and serum alanine aminotransferase (ALT) …
Longitudinal assessment of virological failure and antiretroviral drug resistance among treatment-naive subjects living with HIV
CE Mendes Marcon, AD Schlindwein… - Current HIV …, 2023 - ingentaconnect.com
Introduction: Human immunodeficiency virus (HIV) infection, the etiological agent of
acquired immunodeficiency syndrome (AIDS), is a serious public health issue. Therapeutic …
acquired immunodeficiency syndrome (AIDS), is a serious public health issue. Therapeutic …
HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals
Background The presence of drug resistance mutations (DRMs) against antiretroviral agents
is one of the main concerns in the clinical management of individuals with human …
is one of the main concerns in the clinical management of individuals with human …
HIV-1 integrase drug-resistance mutations in Iranian treatment-experienced HIV-1-infected patients
The latest class of antiretrovirals (ARVs), including integrase strand transfer inhibitors
(INSTIs), has been demonstrated to be effective for antiretroviral therapy (ART). Despite all …
(INSTIs), has been demonstrated to be effective for antiretroviral therapy (ART). Despite all …
The frequency of HIV-1 infection in Iranian children and determination of the transmitted drug resistance in treatment-naive children
M Jarchi, F Bokharaei-Salim, M Esghaei… - Current HIV …, 2019 - ingentaconnect.com
Background: The advent of resistance-associated mutations in HIV-1 is a barrier to the
success of the ARTs. Objective: In this study, the abundance of HIV-1 infection in Iranian …
success of the ARTs. Objective: In this study, the abundance of HIV-1 infection in Iranian …
Investigation of Drug-resistance substitutions in HIV-1 RT Protein in Iranian HIV Infected Patients
B non Dehghani, TN Hashempour… - Russian Journal of …, 2022 - iimmun.ru
Background: Currently, more than 37 million people are living with human
immunodeficiency virus type 1. Reverse transcription (RT) is a main part in the life cycle of …
immunodeficiency virus type 1. Reverse transcription (RT) is a main part in the life cycle of …
[HTML][HTML] The frequency of HIV-1 infection and surveillance drug-resistant mutations determination among Iranians with high-risk behaviors, during 2014 to 2020
S Garshasbi, A Marjani, A Alipour… - Iranian Journal of …, 2021 - ncbi.nlm.nih.gov
Materials and Methods: This cross-sectional study was conducted on 250 individuals with
high-risk behaviors from September 2014 to February 2020. HIV-1 Ag/Ab in plasma samples …
high-risk behaviors from September 2014 to February 2020. HIV-1 Ag/Ab in plasma samples …